Metraipolis › archive › dc_7da74d261ec6

Uncertainty and novel clinical trial designs in oncology - when should equipoise matter? — Europe PMC PMID:42725365

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42725365
DOI
10.1177/17407745261469887
License (as archived)
solo-consultazione
Archived
2026-10-15T15:55:26.177Z
SHA-256 of the archived text
a4fee9cd968d14992af1e7d18841dddc8474862b97f87935f7a5af58588dd31f
Stable URL of this page
https://metraipolis.com/documento/dc_7da74d261ec6

How to cite

Uncertainty and novel clinical trial designs in oncology - when should equipoise matter? — Europe PMC PMID:42725365 — Europe PMC (en), https://europepmc.org/article/MED/42725365 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7da74d261ec6 (Metraipolis archive dc_7da74d261ec6, sha256 a4fee9cd968d14992af1e7d18841dddc8474862b97f87935f7a5af58588dd31f)
BibTeX
@misc{dc7da74d261ec6,
  title = {Uncertainty and novel clinical trial designs in oncology - when should equipoise matter? — Europe PMC PMID:42725365},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42725365},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7da74d261ec6; sha256 a4fee9cd968d14992af1e7d18841dddc8474862b97f87935f7a5af58588dd31f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42725365. Agents can read the archived copy with the MCP tool read_document.